A Zr-based metal-organic framework drug release system with long-lasting antibacterial behavior for accelerating wound healing

Hui-Qian Zheng,Han-Xiao Feng,Bing-Xin Li,Yi-Fei Hui,Yi-Han Lin,Xian-Feng Su,Lai-Peng Yan,Zijie Zhou,Zu-Jin Lin,Fa-qiang Tang
DOI: https://doi.org/10.1039/d4dt02734e
IF: 4
2024-10-30
Dalton Transactions
Abstract:Although various antibacterial strategies have been developed, yet antibiotic chemotherapy remains the primary clinical treatments for bacterial infections. To address the limitations associated with traditional antibiotic therapy like drug brust release, rapid drug clearance, and the emergence of drug resistance, it is highly desired to develop drug release systems that can control and realize sustained drug release to enhance therapeutic efficacy. Herein, we present a novel drug release system, CIP@SU-102, which shows superior and long-lasting antibacterial activity. CIP@SU-102 was readily fabricated by the encapsulation of ciprofloxacin (CIP), a cationic broad-spectrum antibiotic, into an anionic Zr-based metal-organic framework SU-102 through ion-exchange. Notably, the loading capacity and efficiency of CIP were impressively high, reaching 33.3% and 66.8%, respectively. In vitro assays demonstrated that CIP@SU-102 has superior and prolonged antimicrobial activity against Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Remarkably, CIP@SU-102 could retain its antibacterial efficacy even after continuous drug release for 20 days. In vivo assays verified CIP@SU-102 could significantly accelerate the infected wound healing because of its sustained drug release properties. Due to the low cost and biocompatibility of SU-102 as well as the affordability of ciprofloxacin, CIP@SU-102 is a very promising antibacterial agent for long-lasted bacterial disinfection and boosting infected wound healing in actual clinical applications. This work highlights the potential of metal-organic framework-based drug release system for sustained antimicrobial therapy.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?